FindTrial
Sign In

Direct Oral Anticoagulants for Treatment and Prevention of Venous Thromboembolism in Asian Patients: A Systemic Review and Meta-analysis

Direct Oral Anticoagulants for Treatment and Prevention of Venous Thromboembolism in Asian Patients: A Systemic Review and Meta-analysis - DOAC for VTE in Asian patients

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000029961
Enrollment
27032
Registered
2017-11-14
Start date
2017-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous thromboembolism pulmonary embolism deep vein thrombosis

Interventions

None listed

Sponsors

Graduate School of Medicine, Kyoto University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Studies were considered potentially eligible for the current systematic review if they met the following pre-determined criteria: (1) they were RCTs involved more than 100 patients over 18 years of age; (2) fixed dose of DOACs were compared with therapeutic doses of VKA for the treatment and prevention of acute VTE; (3) they reported both the efficacy and safety in Asian patients.

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

MeasureTime frame
The efficacy was recurrent VTE or VTE-related death. The safety was major bleedings or clinically relevant non-major bleedings.—

Countries

Japan,Asia(except Japan),North America,South America,Australia,Europe,Africa

Contacts

Public ContactYugo Yamashita

Graduate School of Medicine, Kyoto University Department of Cardiovascular Medicine

yyamashi@kuhp.kyoto-u.ac.jp075-751-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026